Sputum colour in non-CF bronchiectasis: The original neutrophil biomarker

Respirology

Volumn 19, Issue 2, 2014, Pages 153-154

  Chalmers, James D ^a   Finch, Simon ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

bronchiectasis; elastase; exacerbation; neutrophil; sputum.

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GELATINASE B; LEUKOCYTE ELASTASE; PROTEINASE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BRONCHIECTASIS; CELL COUNT; CILIARY MOTILITY; COLOR; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EDITORIAL; ENZYME ACTIVITY; ENZYME RELEASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY CELL; LUNG FUNCTION; NATIONAL HEALTH ORGANIZATION; NEUTROPHIL COUNT; NON CYSTIC FIBROSIS BRONCHIECTASIS; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RESPIRATORY TRACT INFLAMMATION; SPIROMETRY; SPUTUM ANALYSIS; CHEMISTRY; COMPLICATION; CYSTIC FIBROSIS; FEMALE; INFLAMMATION; MALE; METABOLISM; SPUTUM;

BIOMARKERS; BRONCHIECTASIS; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; MALE; SPUTUM;

EID: 84892607084     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12228     Document Type: Editorial

References (10)

1. Cole PJ,. Inflammation: a two-edged sword-the model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986; 147: 6-15.
2. Chalmers JD, Hill AT,. Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis. Mol. Immunol. 2013; 55: 27-34.
3. Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ,. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 2001; 56: 366-372.
4. Murray MP, Pentland JL, Turnbull K, MacQuarrie S, Hill AT,. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur. Respir. J. 2009; 34: 361-364.
5. Murray MP, Govan JRW, Docherty CJ, Simpson AJ, Wilkinson TS, Chalmers JD, Greening A, Haslett C, Hill AT,. A randomised controlled trial of nebulised gentamicin in non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2011; 183: 491-499.
6. Chalmers JD, Smith MP, McHugh B, Doherty C, Govan JRW, Hill AT,. Short and long term antibiotic therapy reduces airway and systemic inflammation in non-CF bronchiectasis. Am. J. Respir. Crit. Care Med. 2012; 186: 657-665.
7. Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ,. The sputum colour chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology 2014; 2: 203-210.
8. Chalmers JD, McHugh BJ, Doherty CJ, Govan JRW, Kilpatrick DC, Hill AT,. Mannose binding lectin deficiency is associated with disease severity in non-CF bronchiectasis. Lancet Respir. Med. 2013; 1: 224-232.
9. De Jong PA, Tiddens HA,. Cystic fibrosis specific computed tomography scoring. Proc. Am. Thorac. Soc. 2007; 4: 338-342.
10. Stockley R, De Soyza A, Gunawardena K, Perrett J, Forsman-Semb K, Entwistle N, Snell N,. Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis. Respir. Med. 2013; 107: 524-533.